Yeaman Kevin J's Form 4 filing
Dolby Laboratories, Inc.DLB · filed Jul 17, 2025
- Accession no.
- 0000950170-25-096726
- Filed
- Jul 17, 2025
- Trade date
- Jul 15-16, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $3.17M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yeaman Kevin JCIK 0001200469 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2025 | Class A Common Stock | MOption exerciseAcquired | +25,000 | $45.50 | +$1,137,500 | 139,725 | Indirect | |
| Jul 15, 2025 | Class A Common Stock | MOption exerciseAcquired | +14,875 | $64.60 | +$960,925 | 154,600 | Indirect | |
| Jul 15, 2025 | Class A Common Stock | SSaleDisposed | −39,595 | $74.81F2 | −$2,962,101.95 | 115,005 | Indirect | |
| Jul 15, 2025 | Class A Common Stock | SSaleDisposed | −280 | $75.30F3 | −$21,084 | 114,725 | Indirect | |
| Jul 16, 2025 | Class A Common Stock | MOption exerciseAcquired | +2,491 | $64.60 | +$160,918.6 | 117,216 | Indirect | |
| Jul 16, 2025 | Class A Common Stock | SSaleDisposed | −2,491 | $75.00 | −$186,825 | 114,725 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2025 | Class A Common Stock | MOption exerciseDisposed | −25,000 | $0.00 | $0 | 110,615 | Indirect | |
| Jul 15, 2025 | Class A Common Stock | MOption exerciseDisposed | −14,875 | $0.00 | $0 | 37,942 | Indirect | |
| Jul 16, 2025 | Class A Common Stock | MOption exerciseDisposed | −2,491 | $0.00 | $0 | 35,451 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The shares were sold in multiple transactions at prices ranging from $74.30 to $75.245, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F3
The shares were sold in multiple transactions at prices ranging from $75.30 to $75.305, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.